Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析

◆英語タイトル:Audentes Therapeutics Inc (BOLD) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH487739FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥68,400見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥102,600見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Audentes Therapeutics Inc (Audentes) is a biotechnology company. It focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatment of Pompe disease; AT342, for the treatment of crigler-najjar syndrome; and AT307, for the treatment of CASQ2-related catecholaminergic polymorphic ventricular tachycardia. Audentes offers viral vectors for gene therapy most frequently and track record off adeno-associated virus vector (AAV) in non-pathogenic product, among others. The company has collaboration with various patient, research and medical communities to advance its product candidates. Audentes is headquartered in San Francisco, California, the US.

Audentes Therapeutics Inc Key Recent Developments

Mar 31,2021: Audentes Therapeutics expands mission, becomes Astellas Gene Therapies
Apr 21,2020: Audentes Therapeutics Appoints Julie Person as Senior Vice President, Human Resources
Feb 18,2020: Audentes Therapeutics announces plans to build new State-of-the-Art gene therapy manufacturing facility in Sanford, North Carolina

This comprehensive SWOT profile of Audentes Therapeutics Inc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Audentes Therapeutics Inc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Audentes Therapeutics Inc – Key Information
Audentes Therapeutics Inc – Overview
Audentes Therapeutics Inc – Key Employees
Audentes Therapeutics Inc – Key Employee Biographies
Audentes Therapeutics Inc – Key Operational Heads
Audentes Therapeutics Inc – Major Products and Services
Audentes Therapeutics Inc – History
Audentes Therapeutics Inc – Company Statement
Audentes Therapeutics Inc – Locations And Subsidiaries
Audentes Therapeutics Inc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Audentes Therapeutics Inc – Business Description
Audentes Therapeutics Inc – Corporate Strategy
Audentes Therapeutics Inc – SWOT Analysis
SWOT Analysis – Overview
Audentes Therapeutics Inc – Strengths
Audentes Therapeutics Inc – Weaknesses
Audentes Therapeutics Inc – Opportunities
Audentes Therapeutics Inc – Threats
Audentes Therapeutics Inc – Key Competitors

Section 3 – Company Financial Performance Charts

Audentes Therapeutics Inc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Audentes Therapeutics Inc, Key Information
Audentes Therapeutics Inc, Key Ratios
Audentes Therapeutics Inc, Share Data
Audentes Therapeutics Inc, Major Products and Services
Audentes Therapeutics Inc, History
Audentes Therapeutics Inc, Key Employees
Audentes Therapeutics Inc, Key Employee Biographies
Audentes Therapeutics Inc, Key Operational Heads
Audentes Therapeutics Inc, Other Locations
Audentes Therapeutics Inc, Subsidiaries
Audentes Therapeutics Inc, Key Competitors
Audentes Therapeutics Inc, SWOT Analysis
Audentes Therapeutics Inc, Ratios based on current share price
Audentes Therapeutics Inc, Annual Ratios
Audentes Therapeutics Inc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • CPFL Energia SA (CPFE3):電力:M&Aディール及び事業提携情報
    Summary CPFL Energia S.A. (CPFL), formerly Companhia Paulista de Forca e Luz, is an electric utility, which carries out regulated and non-regulated electricity business. The company through its subsidiaries generates, transmits, distributes and commercializes electricity. It generates electricity us …
  • Lysogene SAS (LYS):製薬・医療:M&Aディール及び事業提携情報
    Summary Lysogene SAS (Lysogene) is a clinical research center that offers basic research and clinical development programs. The center offers clinical development of gene therapy for neurodegenerative disorders such as Parkinson and Alzheimer diseases. It also develops models in gene therapy trials …
  • Valamar Riviera d.d.:企業の戦略・SWOT・財務情報
    Valamar Riviera d.d. - Strategy, SWOT and Corporate Finance Report Summary Valamar Riviera d.d. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • ReShape Lifesciences Inc (RSLS):医療機器:M&Aディール及び事業提携情報
    Summary ReShape Lifesciences Inc (ReShape), formerly known as EnteroMedics Inc is a medical device company that develops minimally invasive medical devices to treat obesity and metabolic diseases. The company develops vBloc, a therapy used in the treatment of gastrointestinal and neurometabolic dise …
  • Cielo Wind Power LP:企業の戦略的SWOT分析
    Cielo Wind Power LP - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • JetBlue Airways Corp:戦略・SWOT・企業財務分析
    JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report Summary JetBlue Airways Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Achillion Pharmaceuticals, Inc.:企業の戦略・SWOT・財務分析
    Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report Summary Achillion Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Air Products and Chemicals Inc (APD):企業の財務・戦略的SWOT分析
    Air Products and Chemicals Inc (APD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Linde AG:企業の戦略・SWOT・財務分析
    Linde AG - Strategy, SWOT and Corporate Finance Report Summary Linde AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Cerus Corp (CERS):製薬・医療:M&Aディール及び事業提携情報
    Summary Cerus Corp (Cerus) is a biomedical products company that focuses in the field of blood transfusion safety. It develops and commercializes the INTERCEPT Blood System to enhance blood safety. INTERCEPT Blood System reduces the risk of transfusion-transmitted infections by inactivating a wide r …
  • Funai Electric Co Ltd (6839):企業の財務・戦略的SWOT分析
    Funai Electric Co Ltd (6839) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Teijin Ltd (3401):製薬・医療:M&Aディール及び事業提携情報
    Summary Teijin Ltd (Teijin) is a technology driven holding company offering solutions in the areas of information and electronics, healthcare, environment and energy and safety and protection. It focuses on the manufacture and sale of aramid fiber, carbon fiber products, synthetic fiber, films, poly …
  • Sime Darby Unimills B.V. :企業の戦略・SWOT・財務情報
    Sime Darby Unimills B.V. - Strategy, SWOT and Corporate Finance Report Summary Sime Darby Unimills B.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Sartorius AG (SRT):企業の財務・戦略的SWOT分析
    Sartorius AG (SRT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • NeuroPace Inc-医療機器分野:企業M&A・提携分析
    Summary NeuroPace Inc (NeuroPace) is a medical device company that designs, develops, manufactures, and markets implantable devices for the treatment of neurological disorders. The company’s products include cutting edge medical devices, RNS systems, patient data management systems, magnet products, …
  • Avadel Pharmaceuticals Plc (AVDL):企業の財務・戦略的SWOT分析
    Avadel Pharmaceuticals Plc (AVDL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Analog Devices, Inc.:企業のM&A・事業提携・投資動向
    Analog Devices, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Analog Devices, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Singapore Press Holdings Limited:企業の戦略・SWOT・財務分析
    Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Singapore Press Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Worthington Industries Inc:戦略・SWOT・企業財務分析
    Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report Summary Worthington Industries Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • California Institute for Biomedical Research:製薬・医療:M&Aディール及び事業提携情報
    Summary California Institute for Biomedical Research (Calibr) is a not for profit organization that offers translational research. The organization discovers and develops therapies for unmet medical needs. It conducts research in the human disease areas of degenerative and age-related diseases, canc …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆